Search
for
Sort by
Research 301–330 of 560
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- Pharmaceutical nanotechnology in Egypt: diverse applications and promising outcomes
- EFFECT OF OBESITY ON GENERAL HEALTH AND ON PAROTID SALIVARY GLANDS OF RATS- HISTOLOGICAL AND ULTRASTRUCTURAL STUDY
- Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations
- Prostate cancer prevention
- The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice
- TFOS Lifestyle: Impact of cosmetics on the ocular surface
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- Scientific opinion on the tolerable upper intake level for selenium
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Dermatofitoses: agentes etiológicos, formas clínicas, terapêutica e novas perspectivas de tratamento
- Single‐stage dorsal inlay split‐skin graft for salvage anterior urethral reconstruction
- Clinically-Relevant Chemotherapy Interactions with Complementary and Alternative Medicines in Patients with Cancer
- Circulating testosterone and feather-gene expression of receptors and metabolic enzymes in relation to melanin-based colouration in the barn owl
- Skin manifestations associated with systemic diseases – Part I
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Hairless and the polyamine putrescine form a negative regulatory loop in the epidermis
- Ligand‐independent Regulation of the hairless Promoter by Vitamin D Receptor<sup>†</sup>
- Skin manifestations associated with systemic diseases – Part II
- Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study
- Long-Term Efficacy of Ritlecitinib up to Month 24 From the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
- Familial hypertriglyceridemia in pregnancy
- Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Tracing Recombinant Bovine Somatotropin Ab(Use) Through Gene Expression in Blood, Hair Follicles, and Milk Somatic Cells: A Matrix Comparison
- Gleason grading controversies: what the chemoprevention trials have taught us
- Hair transparency decoding in Asia: From stylists’ perception to in vitro measurement
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy
- Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata